Results 131 to 140 of about 95,141 (285)

Prevalence and Clinical Characteristics of Systemic Sclerosis in Alaska Native and American Indian Peoples in Alaska

open access: yesACR Open Rheumatology, Volume 8, Issue 1, January 2026.
Objective Systemic sclerosis (SSc) is known to exhibit significant epidemiologic and clinical variation. This study aimed to describe the clinical and epidemiologic characteristics of SSc in Alaska Native and American Indian (AN/AI) individuals in Alaska.
Vivek R. Mehta   +5 more
wiley   +1 more source

Scleroderma [PDF]

open access: yesEar, Nose & Throat Journal, 2011
Michele P, Morrison   +2 more
openaire   +2 more sources

OA16 A great imitator of scleroderma [PDF]

open access: gold, 2022
Alexa Josè   +4 more
openalex   +1 more source

Mapping the Tissue‐of‐Origins of Mesenchymal Stromal Cells in Injury Repair

open access: yesAdvanced Science, Volume 13, Issue 3, 14 January 2026.
This study maps mesenchymal stromal cells (MSCs) across multiple tissues, revealing that bone marrow–derived MSCs mobilize monocytes via CCL2 to promote systemic inflammation but do not migrate to distant organs to form fibrotic or tumor stroma. Instead, local MSCs dominate tissue remodeling, suggesting a “two‐hit” model linking systemic inflammation ...
Xinyu Thomas Tang   +4 more
wiley   +1 more source

Antiphospholipid Syndrome Coexisting With Evans Syndrome and SCL‐70 Antibody Positivity: A Case Report

open access: yesClinical Case Reports, Volume 14, Issue 1, January 2026.
ABSTRACT This case of antiphospholipid syndrome, Evans syndrome, and anti‐Scl‐70 positivity (suggesting early SSc) showed marked symptom improvement with rituximab, but poor prognosis persists. Highlights the need for early diagnosis of overlapping autoimmunity, SSc complication monitoring, and optimized immunotherapy in complex cases.
Chunhua Cao   +4 more
wiley   +1 more source

Author Correction: Fibroblast A20 governs fibrosis susceptibility and its repression by DREAM promotes fibrosis in multiple organs

open access: yesNature Communications, 2023
Wenxia Wang   +23 more
doaj   +1 more source

Rituximab and Intravenous Immunoglobulin (IVIG) for Refractory Eosinophilic Fasciitis: A Case Report

open access: yesClinical Case Reports, Volume 14, Issue 1, January 2026.
ABSTRACT Eosinophilic fasciitis (EF) is a rare condition with an unknown cause. This case study showed that a 40‐year‐old man with EF did not respond to standard treatments but improved after receiving rituximab and intravenous immunoglobulin (IVIG). Further studies are needed to confirm rituximab's effectiveness and long‐term safety for EF.
Maryam Sahebari   +4 more
wiley   +1 more source

The Potential Role of Butyrate in the Pathogenesis and Treatment of Autoimmune Rheumatic Diseases

open access: yesBiomedicines
The gut microbiota is a complex ecosystem of microorganisms residing in the human gastrointestinal tract, playing a crucial role in various biological processes and overall health maintenance.
Carmela Coccia   +13 more
doaj   +1 more source

Home - About - Disclaimer - Privacy